NEW YORK, July 13, 2011 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) previously announced on Form 8-K that the Company’s Certificate of Amendment to its Certificate of Incorporation (the “Amendment”) to implement a 1-for-50 reverse stock split of its common stock, $0.001 par value per share (the “Common Stock”) became effective on June 24, 2011 (the “Effective Time”). The split-adjusted shares of the Company’s Common Stock will begin trading on the OTCBB on July 14, 2011 under the symbol “MHAND,” with a “D” added for 20 trading days to signify that the reverse stock split has occurred. A new CUSIP number has been assigned to the Company’s Common Stock as a result of the reverse split.
